Determination of insulin-related lipohypertrophy frequency and risk factors in patients with diabetes.

Korkmaz F. N., Gökçay Canpolat A., Güllü S.

Endocrinologia, diabetes y nutricion, cilt.69, ss.354-361, 2022 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 69
  • Basım Tarihi: 2022
  • Doi Numarası: 10.1016/j.endinu.2021.07.002
  • Dergi Adı: Endocrinologia, diabetes y nutricion
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED)
  • Sayfa Sayıları: ss.354-361
  • Anahtar Kelimeler: Lipohypertrophy, Uttrasonography, Diabetes mellitus, Insulin treatment, SKIN
  • Ankara Üniversitesi Adresli: Evet

Özet

Introduction: Insulin, which is used in the treatment of diabetes mellitus (DM), may lead to the development of lipohypertrophy (LH) which can negatively affect the management of diabetes mellitus. Two common methods to detect LH are palpation and superficial subcutaneous ultrasonography (SSU). We investigated the frequency of non-palpable LH using SSU, as well as examining risk factors.